切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2024, Vol. 18 ›› Issue (06) : 585 -590. doi: 10.3877/cma.j.issn.1674-3253.2024.06.009

所属专题: 经典病例

临床研究

精索去分化脂肪肉瘤两例并文献复习
司钦亮1, 毕世龙1, 焦慧骁1, 李世照1, 陈哲禹1, 武玉东1,()   
  1. 1.450052 河南,郑州大学第一附属医院泌尿外科
  • 收稿日期:2024-01-17 出版日期:2024-12-01
  • 通信作者: 武玉东
  • 基金资助:
    河南省科技攻关项目(172102310074)

Two cases of dedifferentiated liposarcoma of spermatic cord and literature review

Qinliang Si1, Shilong Bi1, Huixiao Jiao1, Shizhao Li1, Zheyu Chen1, Yudong Wu1,()   

  1. 1.Department of Urology,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China
  • Received:2024-01-17 Published:2024-12-01
  • Corresponding author: Yudong Wu
引用本文:

司钦亮, 毕世龙, 焦慧骁, 李世照, 陈哲禹, 武玉东. 精索去分化脂肪肉瘤两例并文献复习[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 585-590.

Qinliang Si, Shilong Bi, Huixiao Jiao, Shizhao Li, Zheyu Chen, Yudong Wu. Two cases of dedifferentiated liposarcoma of spermatic cord and literature review[J]. Chinese Journal of Endourology(Electronic Edition), 2024, 18(06): 585-590.

目的

探讨精索去分化脂肪肉瘤临床病理特点,诊断与鉴别诊断,治疗及预后。

方法

对在郑州大学第一附属医院确诊的2例精索去分化脂肪肉瘤患者的临床资料进行回顾性分析并对相关文献进行复习总结。

结果

两例患者均表现为右侧腹股沟肿物。病例1行腹股沟病损及右侧睾丸根治性切除术,目前随访6个月,未见复发。病例2就诊于当地卫生院,行肿物活检术,我院病理确诊后未做进一步治疗,目前随访1年,发现局部进展。

结论

精索去分化脂肪肉瘤罕见,常表现为一侧腹股沟无痛性肿物或一侧阴囊异常增大,术前详细的体格检查及影像学检查十分必要,需结合组织病理学、免疫组化、基因检测确诊。手术切除是首选治疗方案,必要时可辅以放化疗、分子靶向治疗,根治性切除术后应密切随访。

Objective

To investigate the clinicopathologic features,diagnosis,differential diagnosis,treatment and prognosis of dedifferentiated liposarcoma of spermatic cord.

Methods

The clinical data of two patients with dedifferentiated liposarcoma of spermatic cord diagnosed in the First Affiliated Hospital of Zhengzhou Universitywere retrospectively analyzed and the related literature was reviewed.

Results

Both patients presented with right groin masses. Case 1 underwent excision of groin lesion and radical excision of right testicle. No recurrence was observed during 6 months'follow-up. Case 2 was admitted to a local health center for tumor biopsy,but no further treatment was given after pathological diagnosis in our hospital. At present,one year follow-up has been conducted and local progress has been found.

Conclusions

Dedifferentiated liposarcoma of spermatic cord is rare and often presents as painless mass in one groin or abnormal enlargement of the scrotum on one side. Detailed preoperative physical examination and imaging examination are necessary and need to be combined with histopathology,immunohistochemistry and genetic testing to confirm the diagnosis. Surgical resection is the preferred treatment,which can be supplemented with chemoradiotherapy and molecular targeted therapy if necessary. Close follow-up should be conducted after radical resection.

图1 精索去分化脂肪肉瘤患者术前超声 图2 精索去分化脂肪肉瘤患者术前CT 图3 精索去分化脂肪肉瘤患者术中快速冰冻病理 图4 精索去分化脂肪肉瘤患者肿物大体标本 图5 精索去分化脂肪肉瘤患者术后病理 图6 精索去分化脂肪肉瘤患者CHOP及MDM2基因FISH检测 图7 精索去分化脂肪肉瘤患者阴囊肿物免疫组化 注:图1为病例1超声示右侧腹股沟(图1a)及阴囊(图1b)肿块呈不均匀强回声,边界清楚;图2为病例1 CT示腹股沟肿物(红色箭头所示)及阴囊肿物(蓝色箭头所示),边界尚清,密度不均匀,动脉期明显不均匀强化;图3为病例1腹股沟肿物术中快速冰冻病理,见梭形细胞肿瘤,有一定的异型性(HE×100); 图4 示病例1腹股沟肿物大小约4.0 cm×2.0 cm×1.5 cm,质中/硬,界欠清(图4a),切面灰黄质中,外似有包膜(图4b);图5为病例1腹股沟肿物术后病理,见梭形细胞和脂肪细胞混合分布,去分化区域呈多形性未分化肉瘤样(HE×100) ;图6为病例1腹股沟肿物CHOP及MDM2基因FISH检测,红色信号示MDM2基因簇状扩增(图6a),CHOP(-) (图6b);图7示病例2 MDM2(图7a)及P16(图7b)免疫组化染色阳性(HE×100)
表1 精索去分化脂肪肉瘤报道文献汇总
[1]
Sbaraglia M,Bellan E,Dei Tos AP. The 2020 WHO Classification of soft tissue tumours: news and perspectives[J]. Pathologica,2021,113(2): 70-84.
[2]
赵明,徐明鑫,王宇彬,等. 去分化脂肪肉瘤的组织学诊断与鉴别诊断[J]. 中华病理学杂志,2019,48(7): 573-579.Zhao M,Xu MX,Wang YB,et al. Updates on histologic diagnosis and differential diagnosis of dedifferentiated liposarcoma[J]. Chin J Pathol,2019,48(7): 573-579.
[3]
郑泽坤,刘卓恒,邹浩,等. 扩大根治性手术切除复发性巨大腹膜后去分化脂肪肉瘤1例[J/OL]. 中华普外科手术学杂志(电子版),2023,17(5):588-590.Zheng ZK,Liu ZH,Zou H,et al. Extended radical surgical resection of recurrent giant retroperitoneal dedifferentiated liposarcoma:a case report[J/OL]. Chin J Oper Proc Gen Surg(Electronic Edition),2023,7(5): 588-590.
[4]
Tyler R,Wanigasooriya K,Taniere P,et al. A review of retroperitoneal liposarcoma genomics[J]. Cancer Treat Rev,2020,86: 102013.
[5]
Li F,Tian R,Yin C,et al. Liposarcoma of the spermatic cord mimicking a left inguinal hernia: a case report and literature review[J]. World J Surg Oncol,2013,11: 18.
[6]
Kryvenko ON,Rosenberg AE,Jorda M,et al. Dedifferentiated liposarcoma of the spermatic cord: a series of 42 cases[J]. Am J Surg Pathol,2015,39(9): 1219-1225.
[7]
Huang LC,Ke CC,Wang CC. Spermatic cord dedifferentiated liposarcoma: a lethal disease disguises as a mundane mishap[J].Asian J Surg,2023,46(7): 2827-2828.
[8]
张颖超,邓先兆,樊友本,等. 右侧睾丸旁去分化脂肪肉瘤术前误诊为阴囊疝一例[J/OL]. 中华疝和腹壁外科杂志(电子版),2020,14(5): 581-583.Zhang YC,Deng XZ,Fan YB,et al. A case of right paratesticular dedifferentiated liposarcoma misdiagnosed as scrotal hernia before operation[J]. Chin J Hernia Abdom Wall Surg Electron Ed,2020,14(5): 581-583.
[9]
王成燃,谷欣权,高吉,等. 原发性精索去分化脂肪肉瘤1例[J].中国实验诊断学,2020,24(5): 855-856.Wang CR,Gu XQ,Gao J,et al. Primary spermatic dedifferentiated liposarcoma: a case report[J]. Chin J Lab Diagn,2020,24(5): 855-856.
[10]
闫学川,于文建. 精索去分化脂肪肉瘤1例报告[J]. 现代泌尿外科杂志,2013,18(6): 534.Yan XC,Yu WJ. Dedifferentiated liposarcoma of spermatic cord: a case report[J]. J Mod Urol,2013,18(6): 534.
[11]
邢俊平,刘希,宁亮. 精索去分化脂肪肉瘤临床与病理分析(1例报道附文献复习)[J]. 中国男科学杂志,2017,31(3): 35-38.Xing JP,Liu X,Ning L. Clinical and pathological analysis of dedifferentiated liposarcoma of spermatic cord[J]. Chin J Androl,2017,31(3): 35-38.
[12]
Lee ATJ,Thway K,Huang P H,et al. Clinical and molecular spectrum of liposarcoma[J]. J Clin Oncol,2018,36(2): 151-159.
[13]
Thway K,Jones RL,Noujaim J,et al. Dedifferentiated liposarcoma:updates on morphology,genetics,and therapeutic strategies[J]. Adv Anat Pathol,2016,23(1): 30-40.
[14]
Traweek RS,Cope BM,Roland CL,et al. Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma[J]. Front Oncol,2022,12:1006959.
[15]
杨邵敏,吴若晨,齐双双,等. 睾丸旁脂肪肉瘤19例临床病理学特征[J]. 中华病理学杂志,2022,51(1): 17-22.Yang SM,Wu RC,Qi SS,et al. Paratesticular liposarcoma: the clinicopathological features of nineteen cases[J]. Chin J Pathol,2022,51(1): 17-22.
[16]
Abdul Razak AR,Bauer S,Suarez C,et al. Co-targeting of MDM2 and CDK4/6 with siremadlin and ribociclib for the treatment of patients with well-differentiated or dedifferentiated liposarcoma:results from a proof-of-concept,phase ib study[J]. Clin Cancer Res,2022,28(6): 1087-1097.
[17]
中国抗癌协会肉瘤专业委员会,中国临床肿瘤学会. 软组织肉瘤诊治中国专家共识(2015年版)[J]. 中华肿瘤杂志,2016,38(4):310-320.Chinese Anti Cancer Association Sarcoma Professional Committee,Chinese Society of Clinical Oncology. Chinese expert consensus on diagnosis and treatment of soft tissue sarcomas (Version 2015)[J].Chin J Oncol,2016,38(4): 310-320.
[18]
Casali PG,Abecassis N,Aro HT,et al. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis,treatment and follow-up[J]. Ann Oncol,2018,29(Suppl 4):iv51-iv67.
[19]
Zhou MY,Bui NQ,Charville GW,et al. Treatment of dedifferentiated liposarcoma in the era of immunotherapy[J]. Int J Mol Sci,2023,24(11): 9571.
[20]
Livingston JA,Bugano D,Barbo A,et al. Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard[J]. Sci Rep,2017,7(1): 11836.
[21]
Gahvari Z,Parkes A. Dedifferentiated liposarcoma: systemic therapy options[J]. Curr Treat Options Oncol,2020,21(2): 15.
[22]
郭曦,庄荣源,周宇红,等. 化疗联合程序性细胞死亡受体1抗体和安罗替尼对晚期去分化脂肪肉瘤的疗效及其安全性[J]. 中华医学杂志,2022,102(31): 2428-2434.Guo X,Zhuang RY,Zhou YH,et al. Efficacy and safety of combination therapy with chemotherapy,programmed death-1 inhibitor and anlotinib in the treatment of advanced dedifferentiated liposarcoma[J]. Natl Med J China,2022,102(31): 2428-2434.
[23]
Dubois-Silva A,Barbagelata-Lopez C. Retroperitoneal dedifferentiated liposarcoma[J]. Intern Emerg Med,2019,14(4):619-620.
[24]
Gamboa AC,Gronchi A,Cardona K. Soft-tissue sarcoma in adults:an update on the current state of histiotype-specific management in an era of personalized medicine[J]. CA Cancer J Clin,2020,70(3):200-229.
[25]
Gronchi A,Strauss DC,Miceli R,et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS):a report on 1007 patients from the multi-institutional collaborative RPS working group[J]. Ann Surg,2016,263(5): 1002-1009.
[1] 侯令密, 谢少利, 陈茂山, 李敬东, Ajedichiga Aduah Emmanuel, 杨宏伟, 高砚春, 幸天勇, 邓世山, 赵小波. E6相关蛋白调节膜联蛋白A2的表达对三阴性乳腺癌裸鼠移植瘤的影响[J]. 中华妇幼临床医学杂志(电子版), 2016, 12(03): 274-279.
[2] 李庆贺, 张家耀, 樊斌, 王宇. 垂体肿瘤转化因子1和Ten-eleven转运因子1在肝细胞癌中的表达及相关性分析[J]. 中华普通外科学文献(电子版), 2021, 15(01): 18-22.
[3] 蔡曼妮, 韩向阳, 黄咏东, 何周桃, 王裕宣, 张东艳, 颜超, 刘宁. 假性蛋白激酶3在结肠息肉癌变过程中的表达意义[J]. 中华普通外科学文献(电子版), 2020, 14(06): 439-442.
[4] 郑泽坤, 刘卓恒, 邹浩, 胡会元, 李妲, 吴巍. 扩大根治性手术切除复发性巨大腹膜后去分化脂肪肉瘤1例[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 588-590.
[5] 罗桓, 王智园, 杨莹, 张映林, 黎贵芸, 李方方, 边莉. 胸壁黏液炎性纤维母细胞肉瘤一例[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 128-131.
[6] 梁海胜, 纪律. 肺癌患者3.0T MRI和PET/CT影像学特征与其肿瘤不同病理特征分析[J]. 中华肺部疾病杂志(电子版), 2020, 13(05): 693-695.
[7] 许立芹, 吕梦源, 冯健. EFhd1蛋白在非小细胞肺癌组织中的表达及临床意义[J]. 中华肺部疾病杂志(电子版), 2019, 12(05): 573-578.
[8] 高显华, 张卫, 白辰光. 免疫组化筛查林奇综合征的缺陷和应对策略[J]. 中华结直肠疾病电子杂志, 2019, 08(05): 439-446.
[9] 赵岭岭, 李景光, 刘艳彩, 吴春平, 刘学刚, 商庆花. 结肠癌中骨桥蛋白与环氧化酶-2的表达及临床意义[J]. 中华结直肠疾病电子杂志, 2019, 08(02): 160-164.
[10] 刘岩, 李慧, 赵丹丹, 程颖. MMR与PD-L1在Ⅱ期术后结直肠癌中的差异性表达[J]. 中华结直肠疾病电子杂志, 2018, 07(06): 562-566.
[11] 牛文博, 吴凤鹏, 刘月平, 周超熙, 张娟, 胡旭华, 李保坤, 王贵英. 新辅助放化疗对局部进展期直肠癌疗效及肿瘤免疫微环境变化的研究[J]. 中华临床医师杂志(电子版), 2023, 17(05): 519-523.
[12] 汪泉, 周英妹, 何颖. p27、cyclin-E在子宫内膜异位症中的表达及其临床意义[J]. 中华临床医师杂志(电子版), 2022, 16(06): 546-552.
[13] 张悦, 顾福嘉. MDR1甲基化对宫颈癌介入栓塞化疗疗效的影响[J]. 中华介入放射学电子杂志, 2020, 08(01): 51-56.
[14] 李欣, 李建盈, 邢萌, 张丽冉, 谢风祥, 王新国, 毕春蕊, 彭德志, 祁德波. 蛋清细胞块制作方法的改良[J]. 中华临床实验室管理电子杂志, 2017, 05(04): 221-225.
[15] 卢晓云, 俞姝含, 吴泽宇, 张其德, 吴沛瑶. CCR2、CCL2、Foxp3在结肠癌组织中的表达及其临床意义[J]. 中华胃肠内镜电子杂志, 2023, 10(01): 52-56.
阅读次数
全文


摘要